What Happens When a Patent Expires? Effects Explained
Published March 25, 2026
When a drug patent expires, prices typically drop 80-90% within two to three years as generic manufacturers enter the market. This is the single largest driver of drug cost savings in the U.S. healthcare system. Here is exactly how the process works, with real examples from our patent database.
The Patent Expiration Timeline
| Phase | Timeline | What Happens |
|---|---|---|
| Pre-expiration | 2-4 years before | Generic manufacturers file Abbreviated New Drug Applications (ANDAs) with FDA |
| Patent challenge | 1-3 years before | Paragraph IV challenges — generics assert patent invalidity or non-infringement |
| First generic entry | Day 1 | First generic enters market, typically at 15-20% discount. 180-day exclusivity for first filer. |
| Multi-source generics | 6-12 months | Additional generics enter. Prices drop 40-60%. |
| Full competition | 1-3 years | 5-10+ generics on market. Prices drop 80-90% from branded level. |
Real-World Price Impact
Historical examples demonstrate the dramatic price effects:
- Lipitor (atorvastatin): Lost patent protection in 2011. Price dropped from ~$5/pill branded to ~$0.10/pill generic — a 98% reduction.
- Humira (adalimumab): Biosimilars entered in 2023. Prices dropped ~30% in year one, with deeper discounts as additional biosimilars launched.
- Gleevec (imatinib): Generic entry in 2016 reduced the price from ~$130/pill to ~$15/pill within two years.
Small Molecules vs. Biologics
The expiration process differs significantly between small-molecule drugs and biologics:
- Small molecules: Generic competition is rapid and deep. Multiple manufacturers can produce exact copies, driving prices down 80-95%. This is the traditional patent cliff.
- Biologics: Biosimilars are not exact copies — they are highly similar but require their own clinical trials. Development costs are higher ($100-300M vs. $1-5M for generics), fewer competitors enter, and price discounts are smaller (20-50%). Biosimilar competition is growing but remains less aggressive than small-molecule generic competition.
For the upcoming timeline of major expirations, see our drug patent cliff 2026-2030. For company portfolio analysis, see strongest patent portfolios.
Frequently Asked Questions
How long do drug patents last?
Drug patents in the U.S. last 20 years from the filing date. However, because drugs take 10-15 years to develop and gain FDA approval, the effective exclusivity period is typically only 5-10 years after market launch. Patent term extensions and regulatory exclusivity can extend protection beyond the base 20-year term.
How much do drug prices drop after patent expiration?
For small-molecule drugs, prices typically drop 80-90% within 2-3 years of the first generic entry. For biologics, biosimilar prices are typically 15-35% lower initially, with deeper discounts as more biosimilars enter the market. The speed and depth of price decline depend on market size and the number of generic/biosimilar competitors.
Can pharmaceutical companies extend patents?
Companies use several strategies to extend market exclusivity: filing continuation patents on drug formulations or delivery methods, obtaining pediatric exclusivity extensions (6 months), seeking new indications that trigger regulatory exclusivity, and creating authorized generics or next-generation formulations.
What is an authorized generic?
An authorized generic is a version of a branded drug sold by or with permission from the brand manufacturer, often through a subsidiary. Authorized generics allow the brand company to capture some generic market share after patent expiry rather than losing all revenue to independent generic manufacturers.
About This Data
Patent data from USPTO PatentsView API. Drug patent information from FDA Orange Book. See our methodology.